Grant Dorsey, M.D., Ph.D.
Assistant Adjunct Professor II
gdorsey@medsfgh.ucsf.edu

Mailing Address:
University of California, San Francisco
Division of Infectious Diseases
Box 0811
1001 Potrero Avenue, SFGH 30 408
San Francisco, CA 94143-0811

Office Location:
San Francisco General Hospital, Bldg. 30, Rm. 408

Research Interests:
Clinical and molecular studies of antimalarial drug resistance and the epidemiology of malaria; Interactions between HIV and malaria

Select Publications:

Dorsey G, Njama D, Kamya MR, Staedke SG, Gasasira A, Rosenthal PJ.  Sulfadoxine/pyrimethamine alone or in combination with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomized trial. Lancet 2002;360:2031-38.

Dorsey G, Vlahos J, Kamya MR, Staedke SG, Rosenthal PJ. Prevention of increasing rates of treatment failure by  combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. Journal of Infectious Diseases 2003;188(8):1231-8.

Nsobya SL, Parikh S, KirondeF, LubegaG, KamyaMR, Rosenthal PJ, Dorsey G. Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children. Journal of Infectious Diseases 2004;189(12):220-6.

Dorsey G, Gasasira AF, Machekano R, Kamya MR, Staedke SG, Hubbard A. The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda. American Journal of Tropical Medicine and Hygiene 2004;71(5):531-6.

Dorsey G, Dokomajilar C, Kiggundu M, Staedke SG, Kamya MR, Rosenthal PJ. Dihydrofolate reductase and dihydropteroate synthase genotypes and clinical response to sulfadoxine-pyrimethamine therapy alone and in combination. American Journal of Tropical Medicine and Hygiene 2004;71(6):758-63.

Education and Training:

M.D., Southwestern Medical Center, University of Texas, Dallas

Ph.D. (Epidemiology), University of California, Berkeley

Residency, University of California, San Francisco

Fellowship, University of California, San Francisco